Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc.（LSTA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · LSTA · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Lisata Therapeutics, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
LSTA 季度内部人买卖趋势
LSTA 内幕交易卖出 · LSTA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · LSTA CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
LSTA 高管卖出股份 · LSTA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jan 9, 2026 | Mazzo David J President & CEO · Director | Award | 81,000 | — | Form 4 |
| Jan 9, 2026 | Mazzo David J President & CEO · Director | Other | 10,503 | $21K | Form 4 |
| Jan 9, 2026 | Mazzo David J President & CEO · Director | Other | 10,515 | $21K | Form 4 |
| Jan 9, 2026 | Mazzo David J President & CEO · Director | Other | 12,224 | $24K | Form 4 |
| Jan 9, 2026 | Mazzo David J President & CEO · Director | Other | 7,854 | $15K | Form 4 |
| Jan 9, 2026 | Nisco James SVP, Fin/Treas, Chief Actg Off | Award | 15,000 | — | Form 4 |
| Jan 9, 2026 | Nisco James SVP, Fin/Treas, Chief Actg Off | Other | 2,131 | $4K | Form 4 |
| Jan 9, 2026 | Nisco James SVP, Fin/Treas, Chief Actg Off | Other | 2,131 | $4K | Form 4 |
| Jan 9, 2026 | Nisco James SVP, Fin/Treas, Chief Actg Off | Other | 1,137 | $2K | Form 4 |
| Jan 9, 2026 | Nisco James SVP, Fin/Treas, Chief Actg Off | Other | 781 | $2K | Form 4 |
| Jan 9, 2026 | Imam Tariq SVP, Bus Dev, General Counsel | Award | 15,000 | — | Form 4 |
| Jan 9, 2026 | Imam Tariq SVP, Bus Dev, General Counsel | Other | 1,401 | $3K | Form 4 |
| Jan 9, 2026 | Imam Tariq SVP, Bus Dev, General Counsel | Other | 840 | $2K | Form 4 |
| Jan 9, 2026 | Imam Tariq SVP, Bus Dev, General Counsel | Other | 747 | $1K | Form 4 |
| Jan 9, 2026 | Imam Tariq SVP, Bus Dev, General Counsel | Other | 513 | $1K | Form 4 |
| Jan 9, 2026 | Buck Kristen K EVP, R&D and CMO | Award | 25,000 | — | Form 4 |
| Jan 9, 2026 | Buck Kristen K EVP, R&D and CMO | Other | 2,982 | $6K | Form 4 |
| Jan 9, 2026 | Buck Kristen K EVP, R&D and CMO | Other | 2,982 | $6K | Form 4 |
| Jan 9, 2026 | Buck Kristen K EVP, R&D and CMO | Other | 3,221 | $6K | Form 4 |
| Jan 9, 2026 | Buck Kristen K EVP, R&D and CMO | Other | 2,147 | $4K | Form 4 |
| Jan 9, 2026 | KLOSK STEVEN M Director | Award | 30,456 | — | Form 4 |
| Jan 9, 2026 | HENSON HEIDI Director | Award | 30,456 | — | Form 4 |
| Jan 9, 2026 | Flowers Cynthia Louise Director | Award | 30,456 | — | Form 4 |
| Jan 9, 2026 | BROWN GREGORY B Director | Award | 30,456 | — | Form 4 |
| Jan 9, 2026 | AZAB MOHAMMAD Director | Award | 30,456 | — | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 LSTA 内幕交易
LSTA 内幕交易
Lisata Therapeutics, Inc.（LSTA）内幕交易数据来源于公司内部人（包括Mazzo David J (President & CEO · Director), Nisco James (SVP, Fin/Treas, Chief Actg Off), Imam Tariq (SVP, Bus Dev, General Counsel)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。LSTA内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Lisata Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
LSTA 内幕交易 · 5个问题Lisata Therapeutics, Inc.（LSTA）的内部人包括高管和董事，如Mazzo David J (President & CEO · Director), Nisco James (SVP, Fin/Treas, Chief Actg Off), Imam Tariq (SVP, Bus Dev, General Counsel)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026